Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Capital Expenditures (2016 - 2026)

Collegium Pharmaceutical has reported Capital Expenditures over the past 10 years, most recently at $5000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 100.56% year-over-year to $5000.0; the TTM value through Dec 2025 reached $319000.0, up 72.43%, while the annual FY2025 figure was $319000.0, 72.43% up from the prior year.
  • Capital Expenditures for Q4 2025 was $5000.0 at Collegium Pharmaceutical, down from $190000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $940000.0 in Q4 2022 and troughed at -$897000.0 in Q4 2024.
  • A 5-year average of $212300.0 and a median of $217000.0 in 2024 define the central range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 382.14% in 2024 and fell as far as 641.32% in 2024.
  • Year by year, Capital Expenditures stood at $515000.0 in 2021, then soared by 82.52% to $940000.0 in 2022, then crashed by 112.87% to -$121000.0 in 2023, then tumbled by 641.32% to -$897000.0 in 2024, then skyrocketed by 100.56% to $5000.0 in 2025.
  • Business Quant data shows Capital Expenditures for COLL at $5000.0 in Q4 2025, $190000.0 in Q3 2025, and -$674000.0 in Q2 2025.